Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Elutia Inc (ELUT)

Elutia Inc (ELUT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 23,208
  • Shares Outstanding, K 42,701
  • Annual Sales, $ 24,380 K
  • Annual Income, $ -53,950 K
  • EBIT $ -31 M
  • EBITDA $ -28 M
  • 60-Month Beta 0.63
  • Price/Sales 0.98
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.74
  • Most Recent Earnings $-0.01 on 11/06/25
  • Next Earnings Date 03/05/26
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.26
  • Growth Rate Est. (year over year) +384,330.77%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5000 +8.70%
on 12/17/25
0.7199 -24.50%
on 12/10/25
-0.1295 (-19.24%)
since 11/26/25
3-Month
0.5000 +8.70%
on 12/17/25
0.9999 -45.64%
on 10/10/25
-0.4487 (-45.22%)
since 09/26/25
52-Week
0.5000 +8.70%
on 12/17/25
4.2400 -87.18%
on 12/27/24
-3.6065 (-86.90%)
since 12/26/24

Most Recent Stories

More News
Aziyo Biologics Welcomes Guido J. Neels to Board

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Aziyo Biologics...

ELUT : 0.5435 (-2.81%)
Elutia to Present at the LD Micro Main Event XIX Conference on Tuesday, October 21

GAITHERSBURG, Md., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a pioneer in drug-eluting biomatrix technologies, today announced that Dr. Randy Mills, President and Chief...

ELUT : 0.5435 (-2.81%)
Elutia Appoints Accomplished MedTech Veteran Guido J. Neels to Board of Directors

Industry leader brings 40 years of executive and board experience across the global medical technology sector GAITHERSBURG, Md., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”...

ELUT : 0.5435 (-2.81%)
Elutia Completes Sale of BioEnvelope to Boston Scientific

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Aziyo Biologics...

ELUT : 0.5435 (-2.81%)
Elutia Announces Closing of BioEnvelope Business Sale to Boston Scientific Corporation for $88 Million

- Strengthened balance sheet to fully fund development and launch of NXT-41 platform - - Biologics for breast reconstruction represents $1.5 billion U.S. total addressable market - GAITHERSBURG,...

ELUT : 0.5435 (-2.81%)
BSX : 96.06 (-0.07%)
Elutia Announces Newly Published Clinical Data Demonstrating that Biologic Envelopes Support CIED Stabilization and Ease of Reoperation

- Findings highlight the potential of antibiotic-eluting bioenvelopes to transform cardiac implantable electronic device (CIED) pocket management - GAITHERSBURG, Md., Sept. 16, 2025 (GLOBE NEWSWIRE)...

ELUT : 0.5435 (-2.81%)
Elutia Announces Sale of BioEnvelope Business to Boston Scientific Corporation for $88 Million

- Transaction affirms the strength of Elutia’s proprietary drug-eluting biologics platform and fully funds advancement of NXT-41 in breast reconstruction - - Company to provide update at the H.C....

ELUT : 0.5435 (-2.81%)
BSX : 96.06 (-0.07%)
Elutia to Participate in Upcoming Investor Conferences

GAITHERSBURG, Md., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a pioneer in drug-eluting biomatrix technologies, today announced that Dr. Randy Mills, President and Chief...

ELUT : 0.5435 (-2.81%)
Elutia Delivers Robust Growth on the Strength of EluPro™ Market Adoption

EluPro™ Q2 revenue up 49% sequentially; Elutia advances next-generation drug-eluting biomatrix for breast reconstruction Conference call today at 5:00 p.m. ET / 2:00 p.m. PT GAITHERSBURG,...

ELUT : 0.5435 (-2.81%)
Elutia to Report Second Quarter 2025 Financial Results on Thursday, August 14, 2025

GAITHERSBURG, Md., July 31, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today announced that it will release...

ELUT : 0.5435 (-2.81%)

Business Summary

Elutia Inc. develops and commercializes biologic products to improve compatibility between medical devices and the patients who need them. Elutia Inc., formerly known as Aziyo Biologics Inc., is based in SILVER SPRING, Md.

See More

Key Turning Points

3rd Resistance Point 0.6178
2nd Resistance Point 0.5926
1st Resistance Point 0.5680
Last Price 0.5435
1st Support Level 0.5182
2nd Support Level 0.4930
3rd Support Level 0.4684

See More

52-Week High 4.2400
Fibonacci 61.8% 2.8113
Fibonacci 50% 2.3700
Fibonacci 38.2% 1.9287
Last Price 0.5435
52-Week Low 0.5000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar